Formulation

Aug 01, 2017
BioPharm International
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
Aug 01, 2017
BioPharm International
Media manufacturers are focused on reducing risk, improving quality and consistency, and managing costs.
Jul 21, 2017
By BioPharm International Editors
Catalent Applied Drug Delivery Institute announced a partnership with Rutgers University to examine the challenges of pediatric drug formulation and delivery.
May 01, 2017
BioPharm International
The unique structures of fusion proteins lead to expression, heterogeneity, and stability issues.
Apr 01, 2017
BioPharm International
Including next-gen antibodies in pharma pipelines is considered essential for future success.
Jan 01, 2017
BioPharm International
Primary packaging and container design reflects a move to patient-friendly formulations and delivery systems.
Nov 01, 2016
BioPharm International
The development of mAb formulations poses challenges at the manufacturing, stability, analytical, and administration levels.
Oct 01, 2016
BioPharm International
An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Oct 01, 2016
BioPharm International
Challenging molecules and markets are driving the development of new solutions for drug delivery.
Oct 01, 2016
BioPharm International
Multiparticulates are increasingly used due to their flexibility in providing controlled-release, fixed-dose combinations, ease of taste-masking, and suitability for pediatric applications
native1_300x100
lorem ipsum